Recent Articles from MarketBeat

MarketBeat is an American financial media company headquartered in Sioux Falls, South Dakota, founded in 2011 by Matthew Paulson as Analyst Ratings Network before rebranding in 2015. The company operates an online platform that delivers real-time financial data, market analysis, and news, aiming to empower individual investors with tools to make informed trading decisions.

Vertex Pharmaceuticals Eyes Nov. 30 Kidney Drug Decision as 2027 Pipeline Milestones Loommarketbeat.com
Vertex Pharmaceuticals (NASDAQ:VRTX) is approaching a Nov. 30 U.S. regulatory decision for its kidney disease drug povetacicept, with a series of clinical readouts expected through 2027 as the company seeks to expand beyond its cystic fibrosis business. Speaking at a Jefferies fireside chat in Lond
Via MarketBeat · November 17, 2026
Powell Industries Q4 Earnings Call Highlightsmarketbeat.com
Powell Industries (NASDAQ:POWL) reported record fiscal 2026 revenue, earnings and orders, as demand from liquefied natural gas projects and data centers helped push its backlog to $2.7 billion. The electrical equipment maker said fourth-quarter revenue rose 33% to $397 million, while net income inc
Via MarketBeat · November 17, 2026
Caterpillar Sees a Bright 2027 as Compact Equipment and Rental Expansion Gains Groundmarketbeat.com
Caterpillar (NYSE:CAT) is expanding its compact equipment and rental businesses to reach smaller contractors and win more large projects, Construction Industries Group President Rod Shurman said during an investor discussion at a Cat Compact store in North Carolina. Shurman said the company is gain
Via MarketBeat · November 17, 2026
Regeneron Pharmaceuticals Sees Growth Ahead, Eyes EYLEA HD Syringe Approvalmarketbeat.com
Regeneron Pharmaceuticals (NASDAQ:REGN) expects its three largest growth drivers to continue supporting revenue growth, while planning higher research and development spending and preparing for a specialty drug launch, executives said at the Jefferies Healthcare Conference. Chief Financial Officer
Via MarketBeat · November 17, 2026
What Midera Food Processing (MFP) Said on Its Q3 Earnings Callmarketbeat.com
Midera Food Processing (NASDAQ:MFP) raised its 2026 sales and adjusted earnings outlook after reporting double-digit third-quarter sales growth and stronger margins in its first full quarter as an independent public company. The food-processing equipment maker reported net sales of $228.9 million,
Via MarketBeat · November 17, 2026
What Oaktree Specialty Lending (OCSL) Said on Its Q4 Earnings Callmarketbeat.com
Oaktree Specialty Lending (NASDAQ:OCSL) reported lower adjusted net investment income for its fiscal fourth quarter and full year, as a smaller average portfolio weighed on investment income. The lender said it plans to focus on resolving troubled investments and putting capital to work in performin
Via MarketBeat · November 17, 2026
NVIDIA's Turbulence Could Have Ripple Effects Across Quantum Computingmarketbeat.com
Via MarketBeat · November 17, 2026
What Energizer (ENR) Said on Its Q4 Earnings Callmarketbeat.com
Energizer (NYSE:ENR) expects free cash flow to rise to approximately $300 million in fiscal 2027, as lower restructuring costs and capital spending help the battery and auto care company direct more cash toward debt reduction. The outlook follows a fiscal 2026 in which free cash flow more than trip
Via MarketBeat · November 17, 2026
What Home Depot (HD) Said on Its Q3 Earnings Callmarketbeat.com
Home Depot (NYSE:HD) reported third-quarter sales growth of 4.9% and updated its full-year outlook after repair and remodeling demand helped comparable sales rise at their fastest pace in four years. The retailer posted sales of $43.4 billion, while companywide and U.S. comparable sales each increa
Via MarketBeat · November 17, 2026
What fuboTV (FUBO) Said on Its Q4 Earnings Callmarketbeat.com
fuboTV (NYSE:FUBO) reported positive fourth-quarter free cash flow and said it will stop reporting quarterly subscriber figures as it shifts its focus toward revenue and profitability following its combination with Hulu + Live TV. The company reaffirmed its target of at least $300 million in adjust
Via MarketBeat · November 17, 2026
Euroseas Q3 Earnings Call Highlightsmarketbeat.com
Euroseas (NASDAQ:ESEA) reported lower third-quarter revenue and net income as it operated a smaller fleet, while raising its quarterly dividend and extending charter coverage for several vessels. The container ship owner reported net revenue of $54.1 million for the quarter, down 5% from $56.9 mill
Via MarketBeat · November 17, 2026
Banking on AI: Can Upstart's New Bank Plan Turn Its Stock Around?marketbeat.com
Via MarketBeat · November 17, 2026
Spire Q4 Earnings Call Highlightsmarketbeat.com
Spire (NYSE:SR) reported a 20% increase in fiscal 2026 adjusted earnings per share from continuing operations and outlined a multiyear growth plan, even as regulatory outcomes and weather-related revenue uncertainty prompted the natural gas utility to reduce its near-term guidance. The company earn
Via MarketBeat · November 17, 2026
Gilead Sciences Maps Growth Beyond BIKTARVY With HIV, Cancer and Inflammation Drugsmarketbeat.com
Gilead Sciences (NASDAQ:GILD) expects HIV and oncology to drive growth through the rest of the decade while it builds an inflammation business for the 2030s, executives said at a London healthcare conference. Chairman and CEO Dan O’Day said the company was coming off its strongest growth in more th
Via MarketBeat · November 17, 2026
What Amer Sports (AS) Said on Its Q3 Earnings Callmarketbeat.com
Amer Sports (NYSE:AS) raised its full-year revenue and earnings guidance after reporting 24% sales growth in the third quarter of 2026, driven by demand for Arc'teryx apparel, Salomon footwear and Wilson tennis products. Adjusted diluted earnings per share rose to $0.42 from $0.33 a year earlier, w
Via MarketBeat · November 17, 2026
Klarna Group Q3 Earnings Call Highlightsmarketbeat.com
Klarna Group (NYSE:KLAR) expects to report positive net income in the fourth quarter after narrowing its loss in the third quarter of 2026, executives said on the company’s earnings call. Growth in U.S. financing and card spending helped lift transaction margin dollars, a key measure of profitabilit
Via MarketBeat · November 17, 2026
MYT Netherlands Parent B.V. Q1 Earnings Call Highlightsmarketbeat.com
MYT Netherlands Parent B.V. (NYSE:MYTE), operating as LuxExperience, raised its fiscal 2027 profitability outlook after reporting faster sales growth and a fourth consecutive quarter of positive adjusted earnings before interest, taxes, depreciation and amortization. For the first quarter ended Sep
Via MarketBeat · November 17, 2026
What Research Solutions (RSSS) Said on Its Q1 Earnings Callmarketbeat.com
Research Solutions (NASDAQ:RSSS) reported lower revenue for its fiscal 2027 first quarter as weakness in document delivery and its consumer business offset growth in corporate subscriptions. Management said demand for its artificial intelligence research tools is growing, including a $1 million annu
Via MarketBeat · November 17, 2026
AECOM Q4 Earnings Call Highlightsmarketbeat.com
AECOM (NYSE:ACM) expects revenue and earnings to grow in fiscal 2027, supported by a record backlog, even as two challenging construction management projects are expected to weigh on cash flow in the first half of the year. The infrastructure consulting company forecast net service revenue growth o
Via MarketBeat · November 17, 2026
What Walt Disney (DIS) Said on Its Q4 Earnings Callmarketbeat.com
Walt Disney (NYSE:DIS) reported fiscal 2026 growth in revenue, operating income and adjusted earnings per share, while outlining plans to increase content spending and generate approximately $3 billion in annual run-rate savings by fiscal 2029. CEO Josh D'Amaro said on the company’s fiscal fourth-q
Via MarketBeat · November 17, 2026
What Elbit Systems (ESLT) Said on Its Q3 Earnings Callmarketbeat.com
Elbit Systems (NASDAQ:ESLT) reported a 17.2% increase in third-quarter revenue and a record $33 billion backlog, as demand for ammunition, electronic warfare systems and other defense products supported growth. The company said it expects revenue to grow in the high teens and margins to expand furth
Via MarketBeat · November 17, 2026
Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its Yearmarketbeat.com
Via MarketBeat · November 17, 2026
The Next Nuclear Opportunity May Be in Fuel, Not Reactors: 3 Stocks to Watchmarketbeat.com
Via MarketBeat · November 17, 2026
Viking Q3 Earnings Call Highlightsmarketbeat.com
Viking (NYSE:VIK) reported higher third-quarter revenue but lower adjusted earnings as historically low water levels disrupted European river cruises, prompting guest cancellations and additional costs. Revenue rose 9.2% from a year earlier to $2.2 billion, supported by fleet expansion and higher r
Via MarketBeat · November 17, 2026
Grupo Supervielle Q3 Earnings Call Highlightsmarketbeat.com
Grupo Supervielle (NYSE:SUPV) lowered its 2026 profitability and loan growth outlook after third-quarter earnings fell from the prior quarter, as lower asset yields compressed lending spreads and a softer economy weighed on fees. The Argentine financial services group reported third-quarter net inc
Via MarketBeat · November 17, 2026
ServiceNow Sees AI Usage Surge as It Raises Annual Contract Value Target to $1.7 Billionmarketbeat.com
ServiceNow (NYSE:NOW) is seeing growing customer use of its artificial intelligence tools, including products that automate finance, procurement and human resources work, according to Josh Kahn, the company’s senior vice president and general manager of Core Business Workflows. Speaking at the 2026
Via MarketBeat · November 17, 2026
OneWater Marine Q4 Earnings Call Highlightsmarketbeat.com
OneWater Marine (NASDAQ:ONEW) reported higher adjusted earnings for fiscal 2026 despite a decline in revenue, as improved margins and lower expenses helped offset a softer boat market. The company forecast further growth in adjusted EBITDA for fiscal 2027 while assuming a flat industry in unit terms
Via MarketBeat · November 17, 2026
What JD.com (JD) Said on Its Q3 Earnings Callmarketbeat.com
JD.com (NASDAQ:JD) returned to revenue growth in the third quarter of 2026 as stronger general merchandise and advertising sales, along with narrower losses in new businesses, helped lift adjusted earnings. Revenue rose 3.5% from a year earlier to CNY 310 billion, while non-GAAP net income attribut
Via MarketBeat · November 17, 2026
Griffon Q4 Earnings Call Highlightsmarketbeat.com
Griffon (NYSE:GFF) expects revenue and adjusted earnings to remain flat in fiscal 2027 after a year of asset transactions, debt reduction and shareholder returns transformed the company into a building products business. The company forecast fiscal 2027 revenue of $1.85 billion and adjusted EBITDA
Via MarketBeat · November 17, 2026
What Similarweb (SMWB) Said on Its Q3 Earnings Callmarketbeat.com
Similarweb (NYSE:SMWB) reported third-quarter revenue growth of 15.6% and its first positive GAAP net income, as AI-related deals drove much of the annual recurring revenue added during the period. The company also raised its full-year revenue and adjusted operating profit guidance. Revenue rose to
Via MarketBeat · November 17, 2026
What Opera (OPRA) Said on Its Q3 Earnings Callmarketbeat.com
Opera (NASDAQ:OPRA) reported third-quarter revenue growth of 20% and raised the low end of its full-year revenue forecast, as advertising and query revenue increased despite changes in the e-commerce and internet search markets. Revenue rose to $182.8 million, while adjusted earnings before interes
Via MarketBeat · November 17, 2026
What NRx Pharmaceuticals (NRXP) Said on Its Q3 Earnings Callmarketbeat.com
NRx Pharmaceuticals (NASDAQ:NRXP) reported higher third-quarter patient revenue and a narrower net loss, while outlining plans to commercialize its first approved drug and advance experimental treatments for depression and other conditions. The company’s preservative-free ketamine product received
Via MarketBeat · November 17, 2026
Tyson Foods' Earnings Beat Hides a Warning for Consumer Staples Dividend Investorsmarketbeat.com
Via MarketBeat · November 17, 2026
3 Stocks in an Overlooked Corner of Infrastructure With Hundreds of Billions at Stakemarketbeat.com
Via MarketBeat · November 17, 2026
Illumina Sees Strong Clinical Demand, but Research Recovery Remains in Questionmarketbeat.com
Illumina (NASDAQ:ILMN) is seeing strong demand for its sequencing instruments from clinical customers, while remaining cautious about a recovery in research spending, Chief Financial Officer Ankur Dhingra said at a company news event. Dhingra said the company was making progress toward a goal, laid
Via MarketBeat · November 17, 2026
Tencent Music Entertainment Group Q3 Earnings Call Highlightsmarketbeat.com
Tencent Music Entertainment Group (NYSE:TME) reported a 6% increase in third-quarter revenue as its newly consolidated Ximalaya audio business, merchandise sales and live performances helped offset pressure on its traditional advertising business. The company generated revenue of CNY 8.9 billion in
Via MarketBeat · November 17, 2026
Tyson Foods' 10% Surge Puts a Breakout in Sight, But Wall Street Remains Cautiousmarketbeat.com
Via MarketBeat · November 17, 2026
Gilead Sciences Bets on HIV Prevention Growth Despite $1.5 Billion Biktarvy Headwindmarketbeat.com
Gilead Sciences (NASDAQ:GILD) expects its expanding HIV prevention portfolio and a potential new cell therapy for multiple myeloma to support growth, even as a negotiated price change for its HIV treatment Biktarvy creates an anticipated $1.5 billion headwind in 2028, Chief Financial Officer Andy Di
Via MarketBeat · November 17, 2026
What Weibo (WB) Said on Its Q3 Earnings Callmarketbeat.com
Weibo (NASDAQ:WB) reported a 7% decline in third-quarter revenue as cautious advertisers and a difficult comparison with last year’s food-delivery marketing surge outweighed spending tied to new product launches and the World Cup. Revenue totaled $410.2 million, including $344.1 million in advertis
Via MarketBeat · November 17, 2026
Microsoft's Outage Barely Moved Its Stock, But a Bigger Risk May Be Buildingmarketbeat.com
Via MarketBeat · November 17, 2026
MongoDB's Biggest Advantage May Be GitLab's Biggest Weaknessmarketbeat.com
Via MarketBeat · November 17, 2026
HUYA Q3 Earnings Call Highlightsmarketbeat.com
HUYA (NYSE:HUYA) reported higher third-quarter revenue and returned to operating profitability as growth in game-related services and advertising offset a decline in live-streaming revenue. Total net revenue rose 3.8% from a year earlier to CNY 1.75 billion. Operating income was approximately CNY 1
Via MarketBeat · November 17, 2026
CRISPR Therapeutics Eyes Late-Stage Trials as Key Data and CASGEVY Demand Buildmarketbeat.com
CRISPR Therapeutics (NASDAQ:CRSP) is preparing to advance several experimental treatments toward late-stage trials, with executives pointing to upcoming data from its cardiovascular and cell therapy programs and growing demand for its commercial product, CASGEVY. CEO Sam Kulkarni said during a Jeff
Via MarketBeat · November 17, 2026
What Trifast (TRI) Said on Its H1 Earnings Callmarketbeat.com
Trifast (LON:TRI) lowered its outlook for the second half of fiscal 2027, citing weaker U.S. automotive demand, disruption linked to the Middle East conflict and competitive pressure on home appliance customers. The revised guidance came as the company reported higher underlying profit for the firs
Via MarketBeat · November 17, 2026
Imperial Brands H2 Earnings Call Highlightsmarketbeat.com
Imperial Brands (LON:IMB) reported a sixth consecutive year of growth in tobacco and next-generation product revenue and adjusted operating profit, as higher cigarette prices offset falling volumes and its newer nicotine products gained market share. For fiscal 2026, tobacco and next-generation pro
Via MarketBeat · November 17, 2026
What Diploma (DPLM) Said on Its H2 Earnings Callmarketbeat.com
Diploma (LON:DPLM) reported 45% earnings per share growth for fiscal 2026 and forecast another year of revenue and earnings growth, although management expects margins and the pace of organic growth to moderate. The company said revenue rose 21%, including 15% organic growth and a 6% contribution f
Via MarketBeat · November 17, 2026
Pfizer CEO Sees Growth Beyond Patent Cliff, Highlights Monthly Obesity Drug Ambitionsmarketbeat.com
Pfizer (NYSE:PFE) expects recently launched medicines and a growing pipeline to help it emerge from a period of patent expirations with high single-digit growth, CEO Albert Bourla said at the Jefferies London Healthcare Conference. Bourla said the loss-of-exclusivity period is expected to last anot
Via MarketBeat · November 17, 2026
What FirstGroup (FGP) Said on Its H1 Earnings Callmarketbeat.com
FirstGroup (LON:FGP) said it expects to maintain adjusted earnings per share for its 2027 financial year despite a first-half decline, as bus profit growth was offset by costs for a new rail service and competition on the East Coast Main Line. The U.K. transport operator reported a 21.2% increase i
Via MarketBeat · November 17, 2026
GSK Targets £40 Billion in Sales as HIV Patent Cliff Loomsmarketbeat.com
GSK (NYSE:GSK) expects to grow through the loss of patent protection for key HIV medicines, relying on a pipeline of new treatments, an expanding oncology business and continued dealmaking, President of Business Development David Redfern said at the Jefferies Healthcare Conference. Redfern said the
Via MarketBeat · November 17, 2026
Cytokinetics Touts MYQORZO Launch Momentum, Plans New FDA Filingmarketbeat.com
Cytokinetics (NASDAQ:CYTK) executives said the company is seeing momentum in the launch of heart drug MYQORZO and is preparing to seek U.S. approval for its use in a second form of hypertrophic cardiomyopathy. Speaking at the UBS Biopharma Conference, President and CEO Robert Blum also announced th
Via MarketBeat · November 17, 2026
Ultragenyx Pharmaceutical Targets 2027 Profitability After Deep Cuts and Gene Therapy Launchesmarketbeat.com
Ultragenyx Pharmaceutical (NASDAQ:RARE) expects to reach profitability in 2027 as it cuts spending, expands sales of existing rare-disease treatments and launches two gene therapies, executives said at the UBS Global Biopharma Conference. CEO Emil Kakkis said the company is heading toward $1 billio
Via MarketBeat · November 17, 2026
Insmed Sees BRINSUPRI Reaching $7 Billion in Peak Sales, Expects Cash-Flow Positive Year Aheadmarketbeat.com
Insmed (NASDAQ:INSM) expects its bronchiectasis drug BRINSUPRI to generate $1.35 billion to $1.4 billion in its first full year of launch, Chief Executive Officer Will Lewis said, as the company looks to reach more patients and expand its pipeline. Speaking at the Jefferies Global Healthcare Confer
Via MarketBeat · November 17, 2026
Solid Biosciences Eyes FDA Fast-Track Path for Duchenne Gene Therapy, Potential 2027 Filingmarketbeat.com
Solid Biosciences (NASDAQ:SLDB) plans to meet with the U.S. Food and Drug Administration before the end of 2026 to discuss a potential accelerated approval pathway for its Duchenne muscular dystrophy gene therapy, CEO Bo Cumbo said at a Jefferies fireside chat. The company has dosed 53 patients wit
Via MarketBeat · November 17, 2026
Rollins Tests AI Marketing as Digital Leads Drop and Growth Target Faces Uncertaintymarketbeat.com
Rollins (NYSE:ROL) is testing new marketing approaches as consumers increasingly use artificial intelligence platforms to find pest-control providers, Chief Financial Officer Will Harkins said at a discussion hosted by RBC analyst Ashish Sabadra. Harkins said the company has brought in multiple mar
Via MarketBeat · November 17, 2026
United Therapeutics Prepares for TYVASO Expansion After $833 Million Quartermarketbeat.com
United Therapeutics (NASDAQ:UTHR) is preparing for a potential expansion of its TYVASO franchise into idiopathic pulmonary fibrosis, while its executives pointed to strong third-quarter sales and a pipeline of regulatory and clinical milestones at the UBS London Healthcare Conference. The company r
Via MarketBeat · November 16, 2026
Agora Q3 Earnings Call Highlightsmarketbeat.com
Agora (NASDAQ:API) reported third-quarter 2026 revenue of $42.1 million, up 19% from a year earlier, as growth in its real-time engagement business and increasing contributions from conversational artificial intelligence products helped drive a third consecutive quarter of accelerating revenue growt
Via MarketBeat · November 16, 2026
Yalla Group Q3 Earnings Call Highlightsmarketbeat.com
Yalla Group (NYSE:YALA) reported a modest increase in third-quarter revenue as new games began contributing to sales, but higher marketing and development expenses weighed on earnings. Management said it expects the gaming business to drive double-digit revenue growth in 2027 while warning that prof
Via MarketBeat · November 16, 2026
Standard Lithium Q3 Earnings Call Highlightsmarketbeat.com
Standard Lithium (NYSEAMERICAN:SLI) expects to make a final investment decision on its South West Arkansas lithium project by the end of the first quarter of 2027, a timeline that means the company expects to forgo a $40 million payment from joint venture partner Equinor. CEO David Park said the co
Via MarketBeat · November 16, 2026
Intermap Technologies Q3 Earnings Call Highlightsmarketbeat.com
Intermap Technologies (TSE:IMP) reported higher third-quarter revenue but a wider loss as delays in an Indonesian mapping procurement and costs associated with its acquisition of PCI Geomatics weighed on results. Revenue rose 5% to $1.8 million, while the net loss widened to $4 million, or $0.05 pe
Via MarketBeat · November 16, 2026
VEON Targets Up to $9 Billion in Revenue by 2030 as Fintech and AI Drive Growthmarketbeat.com
VEON (NASDAQ:VEON) outlined plans to grow revenue by 12% to 15% annually in U.S. dollar terms through 2030, as it expands financial services, entertainment and artificial intelligence offerings on top of its telecommunications networks. At the company’s Capital Markets Day, Chief Executive Officer
Via MarketBeat · November 16, 2026
K92 Mining Q3 Earnings Call Highlightsmarketbeat.com
K92 Mining (TSE:KNT) reported its second-highest quarterly production on record in the third quarter of 2026, but posted a net loss after recording a $90.3 million non-cash deferred tax charge tied to earnings retained in Papua New Guinea. The company produced 49,776 gold equivalent ounces, up abou
Via MarketBeat · November 16, 2026
What PagSeguro Digital (PAGS) Said on Its Q3 Earnings Callmarketbeat.com
PagSeguro Digital (NYSE:PAGS) cut its 2026 gross profit growth forecast after slower-than-expected interest rate reductions in Brazil, even as third-quarter earnings rose on growth in credit and banking and lower funding costs. The company, which operates as PagBank, now expects gross profit to inc
Via MarketBeat · November 16, 2026
Aquestive Therapeutics Eyes Needle-Free Allergy Treatment Launch Ahead of 2027 FDA Decisionmarketbeat.com
Aquestive Therapeutics (NASDAQ:AQST) is preparing for a potential U.S. launch of its needle-free treatment for severe allergic reactions, with an FDA decision expected on March 16, 2027, CEO Dan Barber said at the 2026 Jefferies Global Healthcare Conference. The company’s lead product candidate, An
Via MarketBeat · November 16, 2026
PICS Q3 Earnings Call Highlightsmarketbeat.com
PicPay, operated by PICS (NASDAQ:PICS), reported rapid credit growth and higher third-quarter earnings, while outlining an upcoming change to its loan write-off policy that it expects to reduce fourth-quarter net income by approximately BRL 325 million. The company’s credit portfolio reached BRL 35
Via MarketBeat · November 16, 2026
What Infleqtion (INFQ) Said on Its Q3 Earnings Callmarketbeat.com
Infleqtion (NYSE:INFQ) reported third-quarter revenue growth and maintained its full-year sales guidance, while executives pointed to a quantum computing milestone and rising customer commitments as signs of momentum heading into 2027. Revenue rose 25% from a year earlier to $9.1 million, though it
Via MarketBeat · November 16, 2026
XP Q3 Earnings Call Highlightsmarketbeat.com
XP (NASDAQ:XP) reported higher third-quarter revenue and adjusted earnings as growth in its retail and corporate businesses helped offset a challenging environment for capital markets. The company also announced a new share buyback and dividend, while executives outlined expectations for revenue gro
Via MarketBeat · November 16, 2026
What H&R Real Estate Investment Trust (HR.UN) Said on Its Q3 Earnings Callmarketbeat.com
H&R Real Estate Investment Trust (TSE:HR.UN) reported a decline in third-quarter funds from operations and a drop in net asset value after recording substantial property valuation adjustments, while management said its future strategy would be reviewed by a refreshed board following the failure
Via MarketBeat · November 16, 2026
Omeros Q3 Earnings Call Highlightsmarketbeat.com
Omeros (NASDAQ:OMER) reported higher third-quarter sales of its transplant complication treatment YARTEMLEA and a second consecutive quarter of positive operating cash flow, while a non-cash adjustment tied to its convertible notes pushed the company to a net loss. YARTEMLEA generated $35.9 million
Via MarketBeat · November 16, 2026
What Red Cat (RCAT) Said on Its Q3 Earnings Callmarketbeat.com
Red Cat (NASDAQ:RCAT) withdrew its full-year 2026 revenue target after anticipated funding and contract awards failed to materialize on the expected timeline and its FANG drone was not selected as a finalist in the Drone Dominance II competition. The autonomous systems company reported third-quarte
Via MarketBeat · November 16, 2026
What SharonAI (SHAZ) Said on Its Q3 Earnings Callmarketbeat.com
SharonAI (NASDAQ:SHAZ) expects its annualized revenue run rate to rise to $400 million to $450 million in January 2027, up from approximately $50 million in September, as it brings artificial intelligence computing capacity online for customers. On its third-quarter earnings call, the Australian AI
Via MarketBeat · November 16, 2026
PTC Therapeutics Sees $2 Billion-Plus Sephience Potential, Sets January Guidance Datemarketbeat.com
PTC Therapeutics (NASDAQ:PTCT) expects to provide 2027 sales guidance for its oral phenylketonuria treatment Sephience in January, as executives seek to convince investors that the drug’s strong first year of sales can be sustained. Speaking at the Jefferies Healthcare Conference in London, CEO Mat
Via MarketBeat · November 16, 2026
What Live Oak Acquisition Corp. V (TMS) Said on Its Q3 Earnings Callmarketbeat.com
Teamshares said it expects a surge in acquisitions to drive a sharp increase in earnings by the end of 2026, after completing six deals since the third quarter closed and securing nonbinding agreements for additional businesses. On its third-quarter earnings call, management said revenue rose 24% f
Via MarketBeat · November 16, 2026
Precision Optics Q1 Earnings Call Highlightsmarketbeat.com
Precision Optics (NASDAQ:POCI) reported a 22% increase in fiscal first-quarter revenue and a narrower loss, but executives said a slowdown in satellite component shipments will make the current quarter the weakest of the year. Revenue for the quarter ended September 30, 2026, rose to $8.2 million f
Via MarketBeat · November 16, 2026
Soluna Q3 Earnings Call Highlightsmarketbeat.com
Soluna (NASDAQ:SLNH) reported a wider third-quarter loss as wind farm repairs and higher expenses offset revenue growth, while management said its priority is converting prospective tenants at two artificial intelligence data center campuses into signed leases. Revenue rose 80% from a year earlier
Via MarketBeat · November 16, 2026
What Oncocyte (IMDX) Said on Its Q3 Earnings Callmarketbeat.com
Insight Molecular Diagnostics (IMDX) expects to respond before a January 2027 deadline to the U.S. Food and Drug Administration’s request for more information about its GraftAssureDx kidney transplant test, executives said on the company’s third-quarter earnings call. President and CEO Josh Riggs s
Via MarketBeat · November 16, 2026
Articles from MarketBeat | FWNBC